chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHILLS; FEVER BETWEEN 102 TO 104F; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-MAR-2021 08:00 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On 08-MAR-2021, the patient experienced chills, fever between 102 to 104f, and headache. Laboratory data included: Body temperature (NR: not provided) 102 to 104 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever between 102 to 104f, chills, and headache. This report was non-serious. This case, involving the same patient is linked to 20210329954.
pt recvd vax;next day exp pain of skin on rt,lower anterior chest,& a bruise on rt arm;MD made a dx of shingles & pt was tx w/2 courses of Zovirax;
Around 11 hours after 2nd shot I woke up with chills, full body tingling, nausea, and couldn't get comfortable. About 5.5 hours later I had spiked a fever (101.1 temporal) and bad headache. The fever and headache continued all day. Around 7pm on 2/3 I took 1 extra strength Tylenol. The fever broke by Thursday morning and I was feeling better though I still had a headache. I did take 1 extra strength Tylenol around the clock Thurs into Friday. The headache continued to improve Thursday and finally went away by Saturday evening.
Pericarditis and changes in sense of smell; Pericarditis and changes in sense of smell; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (Pericarditis and changes in sense of smell) and PERICARDITIS (Pericarditis and changes in sense of smell) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAROSMIA (Pericarditis and changes in sense of smell) (seriousness criterion hospitalization), PERICARDITIS (Pericarditis and changes in sense of smell) (seriousness criteria hospitalization and medically significant) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, PAROSMIA (Pericarditis and changes in sense of smell) and PERICARDITIS (Pericarditis and changes in sense of smell) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            Concomitant medications were not provided. Treatment information was not provided.  Patient  height was 185.42 cm  Action taken was not applicable.  company comment  This case concerns a 68-year-old patient, of an unknown gender with no relevant medical history reported, who experienced the unexpected event of parosmia and expected event of pericarditis. The event occurred on an unknown date and it is not clear if it was before or after the vaccination  with the Moderna Covid-19 vaccine. Additional  unexpected event of Inappropriate Schedule of Product Administration was added. The rechallenge was not applicable, as the event occurred on an unknown date. The reporter's assessment is not provided in this case. The benefit-risk relationship of the vaccine is not affected by this report.; Sender's Comments: This case concerns a 68-year-old patient, of an unknown gender with no relevant medical history reported, who experienced the unexpected event of parosmia and expected event of pericarditis. The event occurred on an unknown date and it is not clear if it was before or after the vaccination  with the Moderna Covid-19 vaccine. Additional  unexpected event of Inappropriate Schedule of Product Administration was added. The rechallenge was not applicable, as the event occurred on an unknown date. The reporter's assessment is not provided in this case. The benefit-risk relationship of the vaccine is not affected by this report.
Arm was sore; slight headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore) and HEADACHE (slight headaches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A, 012M20A and 052E21A) for COVID-19 vaccination.     Concurrent medical conditions included Lymphedema.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm was sore) and HEADACHE (slight headaches). At the time of the report, VACCINATION SITE PAIN (Arm was sore) and HEADACHE (slight headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported. Treatment information were not provided.      This case was linked to MOD-2021-350345 (Patient Link).
This spontaneous report as received from a patient's father concerning a 13 year old male patient. Patient's concurrent conditions and relevant medical history was unknown. On 28-JUL-2014 the patient was vaccinated with third dose of GARDASIL (dose and route unspecified). The reporter stated that the patient also received unspecified hepatitis a vaccine, inactivated (manufacturer unknown) at the same time. Concomitant medications were unknown. The reporter stated that the patient felt light-headed about 2-3 minutes after receiving third dose of GARDASIL and the patient sat down immediately due to the reaction. Blood pressure was taken after the reaction and it was normal. The patient was not treated for the adverse event. The patient began recovering about ten to fifteen minutes after experiencing the reaction and the reporter also stated that the patient was still recovering a half hour after receiving the GARDASIL. The reporter stated that the reaction occurred in the physician's office. The outcome of the event was recovering/resolving. The causality of the event with GARDASIL was not reported. Product quality issue was not involved. The patient's father also reported that similar reactions from his other sone and daughter which have been documented in SR #1-12018612746 and SR#1-12018612610. The case is linked to #1407USA013430 and #1407USA013445 via same reporter link. Additional information has been requested.
Narrative:  81-year-old male with past medical history of dementia and bedbound state who presented to the hospital with a chief complaint of cough and fever. Most of the history was obtained from the wife at the bedside as the patient is basically aphasic. Wife states that the patient has had a cough for the past 24 hours. She also states his fever has been up and down. She states that she has felt fine. ER work-up which included routine labs showed the patient had a mild leukocytosis. Patient was also found to be Covid positive. Chest x-ray shows bilateral infiltrates. We were consulted for admission mainly given that the patient was noted to be satting in the 80s requiring oxygen. HOSPITAL COURSE: Pt admitted to the floor. dx Mild acute hypoxic respiratory failure due to Covid/COVID PNA. mild sx noted. noted minimal use of oxygen. hold on remdesivir. continued medications for chronic conditions. pt started on remdesivir and dexamethasone given ongoing use of oxygen, albeit minimal in a functional quadraplegic. pt tolerating medications. pt off oxygen after 48 hours except for overnight use in lieu of cpap . pt able to handle own resp secretions. pt given 3 doses of remdesivir; had gotten 4 doses of dexamthasone. stable for d/c to home on 6/6/22.
Fever 102.5, chills/sweats, whole body hurt, arm hurt the most, some nausea. Last about 1 1/2 days.
Initially baby had vomited couple of times and refused take feeding for couple of days and then it turned into sever Diarrhea with 16-20 Poops a day for a week and baby is mostly on Pedialyte Electrolitic maintenance solution.
Initial report from a healthcare professional on 13 Jan 2010: This patient with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (batch no. 10248P1), IM inadvertent administration on 12 Jan 2010. No adverse event was reported.
On unknown dates in 2016 (reported as "after May 2016"), the patients were vaccinated with improperly stored doses of PROQUAD (rHA), lot # L040412, expiration date 13-APR-2017, dose and route not reported). The vaccine was improperly stored at 9.36 degree Fahrenheit for 10 hours. There was no data logger. Central monitoring was used. There were no previous excursions. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as there is no permission to contact the physician.
tingling on and off; fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Bad history of migraine).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PARAESTHESIA (tingling on and off) and FATIGUE (fatigue). At the time of the report, PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Her physician reported , she was given epitome to prevent anaphylactic reaction.
Thursday 5/5: whole body itchiness Friday 5/6: hives on inner thigh, legs, arms, and head Saturday 5/7: hives remain, fever of 100.3 (oral) at night Sunday 5/8: visit urgent care, got steroid shot, symptoms much improved Monday 5/9: Muscle aches in left arm, spreading to legs and feet by evening. Tuesday 5/10: Whole body muscle aches, unable to get out of bed comfortably. Wednesday 5/11: Aches beginning to subside, still minor aches in arms.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history, current conditions and concomitant medications were not provided. On 11-NOV-2015, the patient was inadvertently vaccinated with improperly stored dose of VAQTA lot # L000718, expiration date 28-APR-2017 (dose and route were not provided). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Adverse effect of other vaccines and biological substances, initial encounter on 2021-01-07.
Dizziness and nausea x 1-2 hours. vomiting, tingling in hands.
Within 30 minutes, Heart began to flutter and head began to swim, Took home Blood pressure which was 193/90.  Had pressure on left side back by bar strap.  Face  skin color was fluctuating between very pale to Normal. Went to ER within one hour of vaccine. Blood pressure was 207/95, heart rate fluctuating between 50-80 within 2-4 minutes.  EKG and others tests were performed which were normal. I was monitored for 3 hours, when blood pressure went down to 166/?? I was released to go home.  No medications were given. Was told to see my primary doctor and start with a cardiologist.  At 10:00, I started sweating profusely and my blood pressure was 123/66. Next day  I felt the heart flutter or felt like heart was jiggling in chest several times, BP was higher than normal at 2:00 in after noon BP was 181/88.  Blood pressure slowly went down when checked every 2 hours.  I also had a weird headache. Today I saw my primary doctor, who advised to take an additional losartan if BP Systolic goes above 175. The heart flutters are less, but I just experienced three episodes this afternoon,(2 days after vaccine). Headache is still the same. (Not good) BP at doctors was 145/88.  A cardiologist appt was made for next week.
Initial report received on 08/Sep/2006 from a health care professional. A 28-year-old female patient with a past medical history of one spontaneous abortion, hypertension, and depression had inadvertently received a 0.5 mL intra-muscular dose of ADACEL, lot number 2557AA, in the left deltoid, on 08/Sep/2006 instead of a DTaP vaccine. The patient's physician did not want the patient to receive the pertussis portion of ADACEL, he only wanted her to receive a Tetanus Diptheria vaccine since she was at 17 weeks gestation. The dates of the patient's last menstrual period was 08/May/2006, and her expected date of delivery is 12/Feb/2007. Per the reporter, the patient has not experienced any adverse events since the vaccination with ADACEL on 08/Sep/2006. Follow-up information received on 27 October 2006. Request for authorization for release of reporter name and contact information to the center specialists was also received. The subject had no concurrent illnesses at the time of the vaccination with ADACEL on 08 September 2006. The ADACEL vaccination was received at 10:00 am on 08 September 2006. It was previously reported that the patient had a history of one spontaneous abortion. Per the reporter, this is not the case. The patient has not had any previous obstetrical history. The date of the subject's last menstrual period was on 06 May 2006, not 08 May 2006 as previously reported. The expected date of delivery remains the same. The subject had an ultrasound on 19 September 2006 that showed a low lying placenta. Per the reporter, the subject has not experienced any other adverse events since the vaccination with ADACEL on 08 September 2006. A Corrective version was created to ammend the outcome/seriousness criteria from Category I to Category II. No new medical information was received.
bad migraine; headache; nauseous; This is a spontaneous report from a contactable healthcare professional (patient).  A 36-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular on 06Jan2021 07:00 to 06Jan2021 07:00 at 0.3 mL, single (SINGLE DOSE) for an unspecified indication.  Medical history included polycystic ovaries (PCOS), endometriosis, irritable bowel syndrome (IBS), and known allergies:  melons, all from unknown dates.  Concomitant medication included amoxicillin, clavulanic acid (AUGMENTIN), ethinylestradiol, etonogestrel (NUVARING), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL), cetirizine hydrochloride (ZYRTEC), diphenhydramine hydrochloride (BENADRYL).  The patient experienced bad migraine, headache and was nauseous on 06Jan2021.  Details were as follows: the patient had a bad migraine for three days after. On the  Wednesday night (13Jan2021) after the injection, the migraine was so bad, that therapeutic measures taken; the patient took an unspecified medication and went to bed. The patient woke up three times in the night with a headache bad enough to make the patient nauseous. The second day was bad but manageable; on the third day it came and went.
i developed severe migraines, and developed a huge rash on my arm at the sight of the injection. I noticed my hair falling out and thinning pout. I am not sure if it was due to having COVID in December or a reaction to the vaccine.
Immediate shoulder pain right after injection, 101degree fever at 4am on 10/09/19, rash on upper chest neck area, persistent shoulder pain continue regardless ibuprofen intake and reported shoulder popping on 10/23
PATIENT WAS ADMINSTERED THE MODERNA VACCINE AT AGE 16 YEARS OLD WHEN IT IS NOT YET APPROVED FOR THIS AGE.
Plum size rash at injection site that is a little warm to the touch. Told her to outline with a marker and if it gets bigger or doesn't resolve in a couple of weeks to see Dr.
Respiratory distress, seizing, cyanotic, A-Fib with RVR occurring less than 24 hours after receiving his second dose of Moderna.
little sorness on your arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date:01-AUG-2022 Reporter's Comment: This case was reported by a consumer via interactive digital media. The reporter stated that, no not at all.  The patient experienced only a little soreness on his/her arm. Additional Supportive Information: The follow up would not possible as no contact details were available.
PATIENT ON 2ND DAY AFTER VACCINATION  COULD NOT STAND OR WALK, COULD NOT UNDERSTAND COMMANDS OR CUES, COULD NOT FEED HERSELF, PRIOR TO VACCINATION AMBULATORY AND FEEDING HERSELF.
Child received vaccine on 4/18/2000 and rash started on 05/05/2000 was diagnosed at the as chicken pox. Light case, some in diaper area and behind knees and underarms doing fine.
Headache, felt like I was starting a bad cold , chills, low grade fever and every joint ached for 36 hours. Then it just went away.
About 5-8 minutes after vaccine given became lightheaded, less verbally responsive. Placed in supine position, eyes closed not verbally responsive for 1-2 minutes. Gradually felt better, verbally responsive all sx resolved within 15 minutes.
He began excessive blinking.  Then woke up in the night with fever, sore neck.  Went to Pediatricians, found nothing.  He has had eye rolls and tics ever since.
Seven days after receiving first dose of Moderna Covid 19 vaccine, patient noticed itching, swelling/heat, and redness at injection site.
Pt returned to clinic approximately 10 min after MMR injection, complaining of feeling dizzy, flushed, chest tightness, SOB, weakness. B/P was 122/86 at 2:30, but 2:40 states she was feeling better.
w/in 30 mins pt became red in face & upper arms; had paliptations, chest tightness, nausea, vomiting, h/a on & off x 3 wks;
fever; headache; muscle/ body ache; chills; legs tingling and numbness; Arm tingling / numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (legs tingling and numbness), PARAESTHESIA (Arm tingling / numbness), PYREXIA (fever), HEADACHE (headache) and MYALGIA (muscle/ body ache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B221A and 040B221A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history were reported for patient.  Concomitant products included LEVOTHYROXINE from 01-Apr-2021 to an unknown date for Hypothyroidism.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PARAESTHESIA (Arm tingling / numbness). On 04-Jun-2021, the patient experienced HYPOAESTHESIA (legs tingling and numbness). On an unknown date, the patient experienced PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/ body ache) and CHILLS (chills). At the time of the report, HYPOAESTHESIA (legs tingling and numbness) and PARAESTHESIA (Arm tingling / numbness) had not resolved and PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/ body ache) and CHILLS (chills) outcome was unknown.            No treatment medication was reported.   This case was linked to MOD-2021-073036 (Patient Link).
Pt complained of a large, red, swollen, circular rash (70mm light red, 30mm induration) on upper back of left arm where MMR was placed 8/18/14. Pt reported pain, tingly on left arm and hand. Pt denied fever, difficulty breathing, hoarseness, wheezing, fast HR, dizziness. Advised pt to call if she has these symptoms or if current symptoms worsen. Advised pt to take Tylenol/Ibuprofen to reduce inflammation and pain.
Patient reports feeling nauseous and lightheaded. Patient appears sweaty, pale, and is vomiting. Assisted patient in to wheelchair and wheeled him to recovery area. Assisted patient to gurney. Vital signs at 1507: BP 122/88, P 74, O2 98%. No known allergies. Provided patient with granola bar and water. After 25 minutes, patient reports feeling back to baseline.
At around 24 hours after the first shot of the Pfizer vaccine, Sunday, April 4th around 9:10am, patients blood pressure dropped dangerously low... about 90 over 30 and she felt extremely weak.  To raise blood pressure she drank water with salt in it.  For the past several days after the first shot, besides headaches she had experienced heart palpitations off and on.  Her heart rate was extremely rapid for the remaining 2 -3  days afterwards.  Reported this to her primary care physician, on April 21st, 2021.  Doctor advised that if this happens again patient should go straight to the emergency room at a hospital as it is life threatening to have blood pressure drop that low.  Doctor  advised not to get the second dose of the Pfizer vaccine, which is scheduled for patient tomorrow, Saturday, April 24th since the first dose already provides 85% protection and we do not want to risk her to experience this situation again.  Reported this only to VAERS only this week as we were not aware that we can report it.  Also the submit button has not been working that is why it is being submitted today, Friday, April 23rd, 2021.  Called the AZ POD hotline and the advisor advised us to keep the appointment for the second dose and to also talk to doctors on site.  Despite notifying her that patients primary care physician advised not to get the second dose the advisor on the phone stated to have patient get the second dose of the Pfizer vaccine.
Patient passed-out and fell on the floor right after receiving the vaccine in the pharmacy. He regained consciousness shortly after without any intervention. We contacted 911 but refused further medication intervention. Patient monitored for 30 minutes and was able to walk out of the pharmacy.
patient experience extreme muscle tightness around hip area, and severe back pain, dizziness, blurred vision, increase heart rate,  patient was monitor for sign of anaphylaxis , pt have no sign and symptom of anaphylaxis, 2 minutes after reaction, patient felt no more tightness, pain go away, heart feels normal, patient was monitor for 30 minutes, blood pressure was taken, 141/91, patient have high blood pressure and forgot to take medication in the morning, advise pt to take medication as soon as possible, patient state no more blurred vision, no more dizziness, no other adverse reaction, advise patient to go to pcp, and advise patient to come back at 5 pm to check blood pressure,
I61.9 - ICH (intracerebral hemorrhage) (CMS/HCC) I60.9 - SAH (subarachnoid hemorrhage) (CMS/HCC